From: The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses
Variable | No. of patients (%) |
---|---|
Comorbiditiesa | |
Malignancy | 32 (34.9) |
Diabetes mellitus | 21 (24.4) |
Liver cirrhosis | 14 (16,3) |
Liver transplantation | 10 (11.6) |
Direct cause of abscess | |
Bile duct stenosis/obstruction | 27 (31.4) |
Anastomosis leakage | 13 (15.1) |
Biliary infection | 13 (15.1) |
Superinfected liver metastasis | 8 (9.3) |
Ischemic | 5 (5.8) |
Intra-abdominal infection | 2 (2.3) |
Non-intestinal sepsis | 4 (4.7) |
Cryptogenic | 14 (16.3) |
History of prior abdominal surgery | 40 (57.0) |
History of prior ERCP/PTCD | 56 (53.5) |
PLA under laid-in biliary stent | 33 (38.4) |
Initial symptomsa | |
Fever | 51 (59.3) |
Right upper quadrant pain | 41 (47.7) |
Chills | 14 (16.3) |
Jaundice | 10 (11.6) |
Unspecific abdominal pain | 6 (7.0) |
Other | 30 (34.9) |
None | 3 (3.5) |
Number of abscess | |
One | 57 (66.3) |
Two | 12 (14.0) |
Multiple | 17 (19.8) |
Size of abscess (diameter) | |
< 5 cm | 25 (29.1) |
5–10 cm | 33 (38.4) |
> 10 cm | 11 (12.8) |
Not documented | 17 (19.8) |